Cells help immune system tolerate friendly gut bacteria

Immune cells called group 3 innate lymphoid cells play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.

Researchers identify the target of immune attacks on liver cells

A new study from Weill Cornell Medicine researchers helps to explain the dynamics underlying liver damage that can accompany type 2 diabetes and obesity. 

Vaccination exposes latent HIV in lab studies

Vaccination with a SARS-CoV-2 mRNA vaccine revealed HIV hiding in immune cells in blood from people with HIV, according to lab research led by Weill Cornell Medicine investigators.

Three projects awarded Belonging at Cornell innovation grants

The Presidential Advisors on Diversity and Equity have awarded three Belonging at Cornell innovation grants for 2022 programming, for projects addressing a range of topics involving diversity, equity and inclusion on all of Cornell’s campuses.

Staff News

Two-medication strategy offers benefits and risks after bypass surgery

A new analysis shows that a combination of two anti-platelets drugs can benefit patients after the most common type of cardiac surgery – while also increasing the risk of potentially dangerous bleeding.

Circadian clocks play key role in fat cell growth

Disruption of the circadian clocks that keep the body and its cells entrained to the 24-hour day-night cycle plays a critical role in weight gain, according to a pair of studies by Weill Cornell Medicine investigators.  

White coat ceremony ushers in Class of 2026

On Aug. 16, the Class of 2026 received their short white coats during a Weill Cornell Medicine ceremony, officially marking the beginning of their medical educations.

CALS senior rescues man from NYC subway tracks

Bryce Demopoulos ’23 rescued a man from the subway tracks in New York City Aug. 4, seconds before an incoming train pulled into the station.

Dr. Jedd Wolchok to lead Meyer Cancer Center

Wolchok, an internationally acclaimed medical oncologist, will lead a clinical enterprise dedicated to translating groundbreaking discoveries on the underlying causes of cancer into cutting-edge treatment approaches and personalized therapies to improve patient outcomes.